Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: Risk without reward

被引：16

作者：

Abbas, UL ^{[1
]}

Mellors, JW ^{[1
]}

机构：

[1] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15260 USA

来源：

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 2002年 / 99卷 / 21期

关键词：

D O I：

10.1073/pnas.212518999

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：13377 / 13378

页数：2

共 27 条

[1] Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection [J].

Bonhoeffer, S ;

Rembiszewski, M ;

Ortiz, GM ;

Nixon, DF .

AIDS, 2000, 14 (15) :2313-2322

[2] Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection [J].

Carcelain, G ;

Tubiana, R ;

Samri, A ;

Calvez, V ;

Delaugerre, C ;

Agut, H ;

Katlama, C ;

Autran, B .

JOURNAL OF VIROLOGY, 2001, 75 (01) :234-241

[3] Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells:: Implications for the development of therapeutic strategies [J].

Chun, TW ;

Justement, JS ;

Moir, S ;

Hallahan, CW ;

Ehler, LA ;

Liu, SY ;

McLaughlin, M ;

Dybul, M ;

Mican, JM ;

Fauci, AS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) :253-258

[4] HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression [J].

Davey, RT ;

Bhat, N ;

Yoder, C ;

Chun, TW ;

Metcalf, JA ;

Dewar, R ;

Natarajan, V ;

Lempicki, RA ;

Adelsberger, JW ;

Millers, KD ;

Kovacs, JA ;

Polis, MA ;

Walker, RE ;

Falloon, L ;

Masur, H ;

Gee, D ;

Baseler, M ;

Dimitrov, DS ;

Fauci, AS ;

Lane, HC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) :15109-15114

[5] Mutation takes no vacation: Can structured treatment interruptions increase the risk of drug-resistant HIV-1? [J].

Dorman, KS ;

Kaplan, AH ;

Lange, K ;

Sinsheimer, JS .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (05) :398-402

[6] Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters [J].

Dybul, M ;

Chun, TW ;

Yoder, C ;

Hidalgo, B ;

Belson, M ;

Hertogs, K ;

Larder, B ;

Dewar, RL ;

Fox, CH ;

Hallahan, CW ;

Justement, JS ;

Migueles, SA ;

Metcalf, JA ;

Davey, RT ;

Daucher, M ;

Pandya, P ;

Baseler, M ;

Ward, DJ ;

Fauci, AS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (26) :15161-15166

[7] The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection [J].

García, F ;

Plana, M ;

Ortiz, GM ;

Bonhoeffer, S ;

Soriano, A ;

Vidal, C ;

Cruceta, A ;

Arnedo, M ;

Gil, C ;

Pantaleo, G ;

Pumarola, T ;

Gallart, T ;

Nixon, DF ;

Miró, JM ;

Gatell, JM .

AIDS, 2001, 15 (09) :F29-F40

[8] Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy [J].

Haslett, PAJ ;

Nixon, DF ;

Shen, Z ;

Larsson, M ;

Cox, WI ;

Manandhar, R ;

Donahoe, SM ;

Kaplan, G .

JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (04) :1264-1272

[9] Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression [J].

Hatano, H ;

Vogel, S ;

Yoder, C ;

Metcalf, JA ;

Dewar, R ;

Davey, RT ;

Polis, MA .

AIDS, 2000, 14 (10) :1357-1363

[10] Structured intermittent treatment for HIV disease: Necessary concession or premature compromise? [J].

Havlir, DV .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) :4-6

← 1 2 3 →